This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Celldex Therapeutics Inc (CLDX)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash and Equivalents 169.40M 24.90M 11.90M 21.29M
Receivables 489.00K 44.00K 170.00K 324.00K
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 305.19M 85.11M 54.68M 62.95M
Property, Plant & Equipment, Gross 21.96M 19.53M 19.46M 19.61M
Accumulated Depreciation & Depletion 11.99M 12.32M 10.37M 8.77M
Property, Plant & Equipment, Net 9.97M 7.20M 9.09M 10.83M
Intangibles 22.82M 23.83M 24.92M 26.84M
Other Non-Current Assets 148.00K 424.00K 329.00K 363.00K
Total Non-Current Assets 41.91M 40.43M 43.31M 47.00M
Liabilities & Shareholder Equity
Total Assets 347.10M 125.54M 97.99M 109.94M
Accounts Payable 2.24M 745.00K 935.00K 931.00K
Short Term Debt 0.00 5.59M 6.14M 13.52M
Other Current Liabilities 928.00K 388.00K 219.00K 818.00K
Total Current Liabilities 20.35M 17.68M 14.30M 20.21M
Long Term Debt 0.00 5.75M 9.01M 8.89M
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 6.95M 6.34M 5.97M 5.59M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 6.95M 12.08M 14.97M 14.48M
Total Liabilities 27.30M 29.77M 29.27M 34.69M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 319.80M 95.77M 68.72M 75.26M
Common Par 89.00K 64.00K 44.00K 32.00K
Additional Paid In Capital 662.72M 357.09M 271.03M 232.68M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -345.68M -264.13M -205.01M -160.21M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 2.67M 2.74M 2.65M 2.75M
Total Capitalization 319.80M 101.52M 77.73M 84.14M
Total Equity 319.80M 95.77M 68.72M 75.26M
Total Liabilities & Stock Equity 347.10M 125.54M 97.99M 109.94M
Total Common Shares Outstanding 89.25M 64.36M 44.21M 32.06M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 79.78M 57.71M 39.50M 31.87M
Diluted Weighted Shares Outstanding 79.78M 57.71M 39.50M 31.87M
Number of Employees 120 106 103 94
Number of Part-Time Employees 9 6 0 6

CLDX Celldex Therapeutics Inc

Analysts Ratings for CLDX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 7 7 7 7
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

Brokerage Partners

CLDX Chatter

Select the service that is right for you!

Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs